This IDC Perspective shares insights generated from the McKinsey Life Sciences Conference held in New York on July 30 and 31 on the evolving biopharma landscape, the impact of agentic AI, launch strategies, and women's health."The life sciences industry is experiencing massive disruption, and it is exploring every avenue possible to sustain growth and scale innovation. While investments in agentic AI are scaling, that alone is not the answer. Beyond the tech, the greatest innovation lies in transforming organizational culture. That's the real disruptor," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology, IDC.

Product Code: US53872825